http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DO-P2014000271-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef4f341fe4f2caf061611a818576e40
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83b6f0b0a46085db80858110aa0cd7cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40007c3d73cb35179a15b09934d92cf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a6d4063a44b7746b9d83d9a0f64efae
publicationDate 2015-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DO-P2014000271-A
titleOfInvention NEW DOSAGE FORM AND FORMULATION OF ABEDITEROL
abstract The present invention provides, a pharmaceutical composition in the form of dry powder for inhalation comprising abediterol or a pharmaceutically acceptable salt thereof in admixture with a pharmaceutically acceptable inert excipient, which provides upon inhalation a dose equivalent to a measured nominal dose of about 1 , 25 or about 2.5 free birchterol base administered with the GenuairĀ® inhaler. The present invention also provides said pharmaceutical composition for use in the treatment of a respiratory disease such as asthma and chronic obstructive pulmonary disease COPD.
priorityDate 2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11519741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11962616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453965085

Total number of triples: 30.